ArticleBiomedicine & pharmacotherapy = Biomedecine & pharmacotherapie2024

PSMA-targeted combination brusatol and docetaxel nanotherapeutics for the treatment of prostate cancer.

Tayo Alex Adekiya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.